| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Distinct Epidemiology and Clinical Consequence of Classic Versus Rare EGFR Mutations in Lung Adenocarcinoma.
|
J Thorac Oncol
|
2015
|
2.17
|
|
2
|
Proteoglycans and tumor progression: Janus-faced molecules with contradictory functions in cancer.
|
Semin Cancer Biol
|
2002
|
1.35
|
|
3
|
Efficacy of a leptin receptor antagonist peptide in a mouse model of triple-negative breast cancer.
|
Eur J Cancer
|
2011
|
1.22
|
|
4
|
Lymphoepithelioma-like carcinoma of the breast: not Epstein-Barr virus-, but human papilloma virus-positive.
|
Hum Pathol
|
2008
|
1.11
|
|
5
|
Design and development of a peptide-based adiponectin receptor agonist for cancer treatment.
|
BMC Biotechnol
|
2011
|
1.09
|
|
6
|
Tumor cell and carcinoma-associated fibroblast interaction regulates matrix metalloproteinases and their inhibitors in oral squamous cell carcinoma.
|
Exp Cell Res
|
2012
|
1.09
|
|
7
|
Decorin-TGFβ axis in hepatic fibrosis and cirrhosis.
|
J Histochem Cytochem
|
2012
|
1.08
|
|
8
|
Ablation of the decorin gene enhances experimental hepatic fibrosis and impairs hepatic healing in mice.
|
Lab Invest
|
2010
|
1.02
|
|
9
|
Claudin-4 differentiates biliary tract cancers from hepatocellular carcinomas.
|
Mod Pathol
|
2006
|
1.00
|
|
10
|
Tumor-produced, active interleukin-1β regulates gene expression in carcinoma-associated fibroblasts.
|
Exp Cell Res
|
2011
|
0.99
|
|
11
|
Syndecan-1 and FGF-2, but not FGF receptor-1, share a common transport route and co-localize with heparanase in the nuclei of mesenchymal tumor cells.
|
PLoS One
|
2009
|
0.97
|
|
12
|
Placental protein 13 (galectin-13) has decreased placental expression but increased shedding and maternal serum concentrations in patients presenting with preterm pre-eclampsia and HELLP syndrome.
|
Virchows Arch
|
2008
|
0.96
|
|
13
|
Molecular characteristics of fibrolamellar hepatocellular carcinoma.
|
Pathol Oncol Res
|
2012
|
0.95
|
|
14
|
Curcumin targets fibroblast-tumor cell interactions in oral squamous cell carcinoma.
|
Exp Cell Res
|
2012
|
0.95
|
|
15
|
Genome-wide screening of genes regulated by DNA methylation in colon cancer development.
|
PLoS One
|
2012
|
0.92
|
|
16
|
Serum levels of angiogenic factors and their prognostic relevance in bladder cancer.
|
Pathol Oncol Res
|
2008
|
0.92
|
|
17
|
Endoscopic diagnosis of cytomegalovirus infection of upper gastrointestinal tract in solid organ transplant recipients: Hungarian single-center experience.
|
Clin Transplant
|
2004
|
0.92
|
|
18
|
Quantitative and qualitative alterations of heparan sulfate in fibrogenic liver diseases and hepatocellular cancer.
|
J Histochem Cytochem
|
2010
|
0.92
|
|
19
|
An immunohistochemical study of colon adenomas and carcinomas: E-cadherin, Syndecan-1, Ets-1.
|
Pathol Oncol Res
|
2009
|
0.91
|
|
20
|
Agrin, a novel basement membrane component in human and rat liver, accumulates in cirrhosis and hepatocellular carcinoma.
|
Lab Invest
|
2006
|
0.91
|
|
21
|
Specific syndecan-1 domains regulate mesenchymal tumor cell adhesion, motility and migration.
|
PLoS One
|
2011
|
0.90
|
|
22
|
Peptide-based leptin receptor antagonists for cancer treatment and appetite regulation.
|
Biopolymers
|
2011
|
0.90
|
|
23
|
Changes of cell adhesion and extracellular matrix (ECM) components in cervical intraepithelial neoplasia.
|
Pathol Oncol Res
|
2005
|
0.90
|
|
24
|
Claudins and tricellulin in fibrolamellar hepatocellular carcinoma.
|
Virchows Arch
|
2011
|
0.90
|
|
25
|
Agrin and CD34 immunohistochemistry for the discrimination of benign versus malignant hepatocellular lesions.
|
Am J Surg Pathol
|
2009
|
0.90
|
|
26
|
Decorin interferes with platelet-derived growth factor receptor signaling in experimental hepatocarcinogenesis.
|
FEBS J
|
2013
|
0.89
|
|
27
|
Comparison of the expression of agrin, a basement membrane heparan sulfate proteoglycan, in cholangiocarcinoma and hepatocellular carcinoma.
|
Hum Pathol
|
2007
|
0.89
|
|
28
|
Marked increase of CYP24A1 mRNA level in hepatocellular carcinoma cell lines following vitamin D administration.
|
Anticancer Res
|
2012
|
0.89
|
|
29
|
Validation of circulating MMP-7 level as an independent prognostic marker of poor survival in urinary bladder cancer.
|
Pathol Oncol Res
|
2011
|
0.89
|
|
30
|
Deletion analysis of tumor and urinary DNA to detect bladder cancer: urine supernatant versus urine sediment.
|
Oncol Rep
|
2007
|
0.89
|
|
31
|
Agrin immunohistochemistry facilitates the determination of primary versus metastatic origin of liver carcinomas.
|
Hum Pathol
|
2010
|
0.89
|
|
32
|
Preclinical advantages of intramuscularly administered peptide A3-APO over existing therapies in Acinetobacter baumannii wound infections.
|
J Antimicrob Chemother
|
2010
|
0.88
|
|
33
|
Detection of bladder cancer from the urine using fluorescence in situ hybridization technique.
|
Pathol Oncol Res
|
2007
|
0.88
|
|
34
|
Toward understanding the role of leptin and leptin receptor antagonism in preclinical models of rheumatoid arthritis.
|
Peptides
|
2011
|
0.88
|
|
35
|
Designer peptide antagonist of the leptin receptor with peripheral antineoplastic activity.
|
Peptides
|
2013
|
0.87
|
|
36
|
Prognostic significance of high-risk HPV status in advanced cervical cancers and pelvic lymph nodes.
|
Gynecol Oncol
|
2005
|
0.86
|
|
37
|
Phospholipid barrier to fibrinolysis: role for the anionic polar head charge and the gel phase crystalline structure.
|
J Biol Chem
|
2004
|
0.86
|
|
38
|
Expression of matrilin-2 in liver cirrhosis and hepatocellular carcinoma.
|
Pathol Oncol Res
|
2008
|
0.86
|
|
39
|
Syndecan-1 enhances proliferation, migration and metastasis of HT-1080 cells in cooperation with syndecan-2.
|
PLoS One
|
2012
|
0.85
|
|
40
|
Angiogenic switch of angiopietins-Tie2 system and its prognostic value in bladder cancer.
|
Clin Cancer Res
|
2008
|
0.85
|
|
41
|
Stromal syndecan-1 expression is an adverse prognostic factor in oral carcinomas.
|
Oral Oncol
|
2005
|
0.85
|
|
42
|
The designer leptin antagonist peptide Allo-aca compensates for short serum half-life with very tight binding to the receptor.
|
Amino Acids
|
2013
|
0.83
|
|
43
|
A preliminary comparative study of the prognostic implications of type 2 diabetes mellitus for patients with primary gingival carcinoma treated with surgery and radiation therapy.
|
J Oral Maxillofac Surg
|
2007
|
0.83
|
|
44
|
PP13, maternal ABO blood groups and the risk assessment of pregnancy complications.
|
PLoS One
|
2011
|
0.83
|
|
45
|
Triiodothyronine accelerates differentiation of rat liver progenitor cells into hepatocytes.
|
Histochem Cell Biol
|
2008
|
0.83
|
|
46
|
Multiple splice variants of EWSR1-ETS fusion transcripts co-existing in the Ewing sarcoma family of tumors.
|
Cell Oncol (Dordr)
|
2013
|
0.82
|
|
47
|
Invasive growth and topoisomerase-switch induced by tumorous extracellular matrix in osteosarcoma cell culture.
|
Cell Biol Int
|
2005
|
0.81
|
|
48
|
Antitumoral effects of 9-cis retinoic acid in adrenocortical cancer.
|
Cell Mol Life Sci
|
2013
|
0.80
|
|
49
|
The presence of human papillomavirus 16 in neural structures and vascular endothelial cells.
|
Virology
|
2006
|
0.80
|
|
50
|
Myosin: a noncovalent stabilizer of fibrin in the process of clot dissolution.
|
Blood
|
2003
|
0.79
|
|
51
|
Treatment of refractory hairy cell leukemia with a BRAF-inhibitor: lessons to be learnt.
|
Pathol Oncol Res
|
2014
|
0.78
|
|
52
|
Changes of placental syndecan-1 expression in preeclampsia and HELLP syndrome.
|
Virchows Arch
|
2013
|
0.78
|
|
53
|
[Alterations in microRNA expression patterns in liver diseases].
|
Orv Hetil
|
2010
|
0.78
|
|
54
|
Regulatory role of kinases and phosphatases on the internalisation of caveolae in HepG2 cells.
|
Micron
|
2006
|
0.77
|
|
55
|
Activation of villous trophoblastic p38 and ERK1/2 signaling pathways in preterm preeclampsia and HELLP syndrome.
|
Pathol Oncol Res
|
2015
|
0.77
|
|
56
|
[MicroRNAs in hepatocarcinogenesis].
|
Orv Hetil
|
2012
|
0.77
|
|
57
|
Contribution of neutrophil elastase to the lysis of obliterative thrombi in the context of their platelet and fibrin content.
|
Thromb Res
|
2010
|
0.77
|
|
58
|
[Role of syndecan-1 proteoglycan in the invasiveness of HT-1080 fibrosarcoma].
|
Magy Onkol
|
2006
|
0.77
|
|
59
|
Antiproliferative and antimigratory effects of doxorubicin in human osteosarcoma cells exposed to extracellular matrix.
|
Anticancer Res
|
2005
|
0.76
|
|
60
|
No mutation but high mRNA expression of Coxsackie-Adenovirus Receptor was observed in both dilated and ischemic cardiomyopathy.
|
Forensic Sci Int
|
2011
|
0.76
|
|
61
|
Spatial distribution of keratan sulfate in the rabbit cornea following photorefractive keratectomy.
|
J Refract Surg
|
2005
|
0.75
|
|
62
|
BRCA Mutation-Related and Claudin-Low Breast Cancer: Blood Relatives or Stepsisters.
|
Pathobiology
|
2015
|
0.75
|
|
63
|
[The molecular diagnostics of viruses].
|
Magy Onkol
|
2003
|
0.75
|
|
64
|
[Hepatocellular carcinoma--from macroscopy to molecular pathology].
|
Orv Hetil
|
2010
|
0.75
|
|
65
|
[Clinical observations in cutan mastocytosis].
|
Orv Hetil
|
2013
|
0.75
|
|
66
|
Role of Proteoglycans in Tumor Progression.
|
Pathol Oncol Res
|
1995
|
0.75
|
|
67
|
Utilisation of fluorescent multiplex PCR and laser-induced capillary electrophoresis for the diagnosis of Ewing family of tumours in formalin-fixed paraffin-embedded tissues.
|
J Clin Pathol
|
2012
|
0.75
|
|
68
|
[András Jeney -- 80 years].
|
Magy Onkol
|
2014
|
0.75
|